Position in HAE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$7,881,664
-$3,371,876 QoQ
Shares Held
139,845
-0.4% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in HAE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,402,735,885 across 83 Medical Devices names. HAE ranks #20 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,876,810 | $295,362,082 | |
| 2 | SYK |
Stryker Corp
|
633,935 | $208,304,701 | |
| 3 | MDT |
Medtronic plc
|
2,241,292 | $194,207,951 | |
| 4 | BSX |
Boston Scientific Corp
|
2,674,641 | $167,833,722 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,067,753 | $85,505,660 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
763,138 | $54,320,162 | |
| 7 | DXCM |
Dexcom Inc
|
772,557 | $48,516,579 | |
| 8 | STE |
STERIS plc
|
214,808 | $47,500,493 |
All Filings in HAE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,881,664 | 139,845 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,253,540 | 140,406 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,645,941 | 156,872 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,415,626 | 166,407 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,239,366 | 161,123 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $12,435,176 | 159,262 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $12,719,170 | 158,238 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,374,214 | 161,661 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $13,725,901 | 160,819 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $13,688,269 | 160,078 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $14,595,538 | 162,933 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $13,776,929 | 161,815 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,399,624 | 161,929 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $12,863,364 | 163,552 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,174,751 | 164,457 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $10,274,714 | 157,636 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,405,239 | 148,770 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,741,347 | 145,953 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,976,696 | 141,333 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,346,126 | 140,248 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $15,214,586 | 137,056 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $16,492,831 | 138,887 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $12,130,105 | 139,027 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,871,652 | 143,721 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $15,225,456 | 152,774 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||